Novartis AG
AMINOPYRIDINE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS

Abstract:

The invention relates to a compound of formula (1) in free form or in pharmaceutically acceptable salt form ##STR00001## to pharmaceutical compositions comprising said compound and to the use of said compound in the treatment of heterotopic ossification and fibrodysplasia ossificans progressiva.